Blog
RSS FeedPosted by Michael Wonder on 10 Jun 2020
Cardiff Oncology announces expanded access program for onvansertib in KRAS mutated metastatic colorectal cancer as follow-on to fast track designation
9 June 2020 - Expanded Access Program provides pathway for patients to gain access to treatment with onvansertib outside of clinical ...
Posted by Michael Wonder on 10 Aug 2017
To speed access to compassionate use, look beyond the FDA
10 August 2017 - In mid-July, the nonpartisan research arm of the federal government, the Government Accountability Office, released its long-awaited ...
Posted by Michael Wonder on 12 Oct 2016
What experimental drug? Most companies don’t post compassionate use policies
11 October 2016 - As patients clamour for greater access to experimental medicines, a survey released Tuesday finds that ...
Posted by Michael Wonder on 02 Jun 2016
Statement from FDA Commissioner Robert Califf on the release of the final individual patient expanded access form
2 June 2016 - Today, the U.S. FDA finalized its efforts to streamline the process used by physicians to request expanded ...